D
Lucid Diagnostics Inc. LUCD
$1.26 $0.086.78% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 83.50% -133.15% 6.71% -12.41% -3.70%
Total Depreciation and Amortization 0.45% -0.45% 3.26% -6.11% -54.29%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -136.09% 3,054.25% -76.70% 75.50% 45.37%
Change in Net Operating Assets 47.87% -242.56% 786.33% 92.74% 42.56%
Cash from Operations 15.37% -26.28% 2.99% 11.38% 8.96%
Capital Expenditure 73.12% 64.09% -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 100.00% -- --
Cash from Investing 73.12% 64.09% 26.00% -- 100.00%
Total Debt Issued -100.00% -98.33% -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 9.16% -- -100.00% -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -100.00% -35.96%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 6.61% -14.23% 19,047.87% -99.19% -37.19%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 104.34% -63.40% 175.44% -7,007.95% -97.43%